Search

Your search keyword '"Hallberg, E"' showing total 384 results

Search Constraints

Start Over You searched for: Author "Hallberg, E" Remove constraint Author: "Hallberg, E"
384 results on '"Hallberg, E"'

Search Results

1. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

9. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis

10. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (vol 5, 4999, 2014)

11. Gunter Blobel: Pioneer of molecular cell biology (1936-2018)

13. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

14. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

15. Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers

16. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

18. RAD51B in familial breast cancer.

19. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

20. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

21. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

22. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

23. PHIP:a novel candidate breast cancer susceptibility locus on 6q14.1

24. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

25. Evidence that the 5p12 variant rs10941679 confers susceptibility to estrogen receptor positive breast cancer through FGF10 and MRPS30 regulation

26. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

27. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

28. RAD51B in familial breast cancer

29. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

30. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

31. Common germline polymorphisms\ud associated with breast cancer-specific survival

32. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

33. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

34. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

35. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

36. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

37. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

38. RAD51B in Familial Breast Cancer

39. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

40. Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs)

41. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

42. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

43. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

44. Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers

45. Genetic Predisposition to In Situ and Invasive Lobular\ud Carcinoma of the Breast

46. Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors

47. A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density

48. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

49. Common germline polymorphisms associated with breast cancer-specific survival

50. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

Catalog

Books, media, physical & digital resources